US Stock MarketDetailed Quotes

CNSP CNS Pharmaceuticals

Watchlist
  • 0.1129
  • -0.0020-1.74%
Close Dec 27 16:00 ET
  • 0.1127
  • -0.0002-0.18%
Post 20:01 ET
6.49MMarket Cap0.00P/E (TTM)

CNS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
24.15%5.63M
-37.20%2.53M
-28.05%3.54M
23.57%18.87M
4.77%5.38M
32.61%4.53M
12.93%4.03M
56.44%4.93M
5.39%15.27M
57.91%5.13M
Selling and administrative expenses
23.20%1.38M
19.64%1.41M
-17.98%1.11M
-20.07%4.77M
-48.54%1.11M
-7.25%1.12M
-12.15%1.18M
7.80%1.36M
27.48%5.97M
140.15%2.15M
-General and administrative expense
23.20%1.38M
19.64%1.41M
-17.98%1.11M
-20.07%4.77M
-48.54%1.11M
-7.25%1.12M
-12.15%1.18M
7.80%1.36M
27.48%5.97M
140.15%2.15M
Research and development costs
24.47%4.24M
-60.76%1.12M
-31.88%2.43M
51.56%14.1M
43.25%4.27M
54.47%3.41M
28.10%2.85M
88.89%3.57M
-5.15%9.3M
26.61%2.98M
Operating profit
-24.15%-5.63M
37.20%-2.53M
28.05%-3.54M
-23.57%-18.87M
-4.77%-5.38M
-32.61%-4.53M
-12.93%-4.03M
-56.44%-4.93M
-5.39%-15.27M
-57.91%-5.13M
Net non-operating interest income expense
107.99%22.97K
-163.05%-2.62K
101.95%106
297.55%13.88K
278.24%4.12K
2,152.97%11.05K
357.73%4.15K
-111.85%-5.44K
24.32%-7.03K
-3.31%-2.31K
Non-operating interest income
95.84%25.23K
-76.35%1.85K
--6.73K
--27.69K
--7K
--12.88K
--7.8K
--0
--0
--0
Non-operating interest expense
22.85%2.26K
22.27%4.46K
21.87%6.63K
96.46%13.81K
24.61%2.88K
241.64%1.84K
126.57%3.65K
111.85%5.44K
-24.32%7.03K
3.31%2.31K
Other net income (expense)
Income before tax
-23.95%-5.61M
37.07%-2.53M
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
Income tax
Net income
-23.95%-5.61M
37.07%-2.53M
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
Net income continuous Operations
-23.95%-5.61M
37.07%-2.53M
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
Minority interest income
Net income attributable to the parent company
-23.95%-5.61M
37.07%-2.53M
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-23.95%-5.61M
37.07%-2.53M
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
Basic earnings per share
99.54%-0.25
87.04%-6.72
84.17%-20.5
10.87%-500
75.64%-43.2473
57.70%-54.14
61.15%-51.86
-6.15%-129.5
32.00%-561
1.39%-177.5
Diluted earnings per share
99.54%-0.25
87.04%-6.72
84.17%-20.5
10.87%-500
75.64%-43.2473
57.70%-54.14
61.15%-51.86
-6.15%-129.5
32.00%-561
1.39%-177.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 24.15%5.63M-37.20%2.53M-28.05%3.54M23.57%18.87M4.77%5.38M32.61%4.53M12.93%4.03M56.44%4.93M5.39%15.27M57.91%5.13M
Selling and administrative expenses 23.20%1.38M19.64%1.41M-17.98%1.11M-20.07%4.77M-48.54%1.11M-7.25%1.12M-12.15%1.18M7.80%1.36M27.48%5.97M140.15%2.15M
-General and administrative expense 23.20%1.38M19.64%1.41M-17.98%1.11M-20.07%4.77M-48.54%1.11M-7.25%1.12M-12.15%1.18M7.80%1.36M27.48%5.97M140.15%2.15M
Research and development costs 24.47%4.24M-60.76%1.12M-31.88%2.43M51.56%14.1M43.25%4.27M54.47%3.41M28.10%2.85M88.89%3.57M-5.15%9.3M26.61%2.98M
Operating profit -24.15%-5.63M37.20%-2.53M28.05%-3.54M-23.57%-18.87M-4.77%-5.38M-32.61%-4.53M-12.93%-4.03M-56.44%-4.93M-5.39%-15.27M-57.91%-5.13M
Net non-operating interest income expense 107.99%22.97K-163.05%-2.62K101.95%106297.55%13.88K278.24%4.12K2,152.97%11.05K357.73%4.15K-111.85%-5.44K24.32%-7.03K-3.31%-2.31K
Non-operating interest income 95.84%25.23K-76.35%1.85K--6.73K--27.69K--7K--12.88K--7.8K--0--0--0
Non-operating interest expense 22.85%2.26K22.27%4.46K21.87%6.63K96.46%13.81K24.61%2.88K241.64%1.84K126.57%3.65K111.85%5.44K-24.32%7.03K3.31%2.31K
Other net income (expense)
Income before tax -23.95%-5.61M37.07%-2.53M28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M
Income tax
Net income -23.95%-5.61M37.07%-2.53M28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M
Net income continuous Operations -23.95%-5.61M37.07%-2.53M28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M
Minority interest income
Net income attributable to the parent company -23.95%-5.61M37.07%-2.53M28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -23.95%-5.61M37.07%-2.53M28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M
Basic earnings per share 99.54%-0.2587.04%-6.7284.17%-20.510.87%-50075.64%-43.247357.70%-54.1461.15%-51.86-6.15%-129.532.00%-5611.39%-177.5
Diluted earnings per share 99.54%-0.2587.04%-6.7284.17%-20.510.87%-50075.64%-43.247357.70%-54.1461.15%-51.86-6.15%-129.532.00%-5611.39%-177.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data